The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
morepen labs plans to spin off medical devices business for growth potential
Morepen Labs plans to spin off its medical devices business into a separate unlisted subsidiary within 12-24 months to enhance investor value, with expectations of 25-28% growth. The company aims to expand glucometer production from 2.5 million to 5 million units annually by FY26, targeting regulated markets like the US by FY27. Backward integration efforts are underway, focusing on manufacturing components in India and increasing strip production to 700 million by FY26.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.